A Houston startup has created a web tool for tracking the coronavirus. Pexels

A Houston tech startup has created a web application to give the residents of Harris County all the local information on COVID-19 in the palm of their hand.

Predictive Solutions uses a map tool to indicate the county's nearby testing locations as well as cases that have been self reported in the area through the tool. While not trying to be comprehensive, the website is trying to track trends with the disease.

"We developed the app to help streamline communication between the City of Houston, the healthcare community, aid organizations and Harris County residents, while mitigating the logistical nightmare of making sure presumed cases get tested," says Stewart Severino, co-founder and CEO of Predictive Solutions, in the news release.

While the web app is something consumers can use and report on, it's also something that federal, state and local officials can use as a data solution to predicting the virus' trends.

"By providing a mechanism for the city to monitor testing locations and enabling users to self-report symptoms, Predictive hopes to deliver a platform that can help officials gain a firm handle on the trending virus, allowing for decision-making that's directly informed by data," says Predictive's co-founder and CTO, Theo Patestos, in the release.

The startup is a portfolio company of H Town Incubator, a new coworking space in town that provides its members with services like health care and legal counsel. The app can be accessed online through desktop or mobile.

"This is only a starting point for presenting the data," says Severino, who's also the CEO of H Town Incubator. "We need city and state officials, as well as the public to help make this application useful. The app is only as good as the data it gathers."

A new coworking space plans to debut on Houston's northside. Photo courtesy of H-Town Incubator

Houston coworking concept to launch to arm members with advisers and health insurance options

new to hou

Freelancers and small business owners might not miss the office politics or mandatory training seminars, but there are quite a few things like mentorship and health insurance that most coworking spaces don't provide. A new Houston company hopes to fill the void.

H-Town Incubator is a 30,000-square-foot coworking space on the northside of town with plans to launch officially in January. The space has desk, cubicle, or office membership options, but also provides its members with advisory services, like legal, accounting, marketing, and more.

"What if an entrepreneur, freelancer, or contractor were given access to an hour or so for a month with legal or accounting," says Stewart Severino, CEO of H-Town Incubator. "You have that real coaching available to you."

Another unprecedented perk is that entrepreneurs can have access to affordable health insurance for as low as $60 a month. Severino says that small businesses can even white label this plan so that their team can have their ID cards labeled with their company's information.

"There are so many underinsured and uninsured people and families out there. It's a big deal," Severino tells InnovationMap. "Because of the co-op we have with our insurance partners, we can put together our own plan and offer that to these individuals."

At this point, about 15,000 square feet of space built out with space for 80 to 100 coworkers to work out of 55 cubicles, 30 offices, and other desk space. The second half of the floor could also be developed for additional offices, desks, and cubicles. The space also has two kitchens and conference rooms that Severino says members won't have any limitations on access, like other models that use credit systems.

"Because we're smaller, we can do that," he says. "We don't have to go that route of being too structured."

With easy access to Bush Intercontinental Airport and neighboring communities like The Woodlands and Spring, Severino says he's already seen both local and international opportunities.

Severino says the idea for the space came organically. He was working out of this office and saw connections happening between various industries. That's how he got the idea to build it into coworking space.

With his 20-year marketing career, Severino says he's seen the smoke and mirrors of "dressed-up" coworking spaces on the market today, he wants to provide something deeper for entrepreneurs.

"When things lack substance, that really bothers me on a personal level," he says. "I want to go out and create something that can serve the individual as a whole."

H-Town Incubator will celebrate a grand opening in mid January, but Severino plans to offer free drop-in days for entrepreneurs to take a trial run. Ultimately, Severino hopes the initiative becomes a collaborative space for companies of all phases and industries to work as resources for each other.

"It will be a dynamic place for sure," he says, adding that he expects to add programming to the mix too.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.